Post-earnings recap
Reported
Thu, Aug 4, 2022
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
Est. EPS
—
Est. Rev
—
Impl. Move
—
Collegium Pharmaceutical reported a loss per share of $0.15, significantly missing expectations. Despite the earnings miss, the stock reacted positively, rising 2.55%. This increase may reflect investor optimism or other market factors unrelated to the earnings report.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.15 | N/A | -113.00% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.